New Stock News | Sino Biopharmaceutical Group may postpone its $5 billion Hong Kong IPO plan.

According to sources quoted by the media, the Chinese chemical giant under China National Chemical Corporation (ChemChina), Syngenta, is reportedly delaying its planned $5 billion (approximately HK$39 billion) initial public offering (IPO) in Hong Kong, awaiting a better market environment in the agricultural industry. Sources said that Syngenta's advisory team currently believes that the possibility of going public in 2027 is greater. It was reported that Syngenta had initially planned to submit its listing application in June and hoped to go public at some point this year. However, the company now plans to wait until September or later to submit the listing documents, potentially postponing the IPO until next year. Some sources pointed out that in addition to challenges in the agricultural industry, Syngenta's agricultural seed business is seen as a particularly sensitive area, and the company may need more time to obtain regulatory approval for listing, as well as possibly additional approvals. Discussions are ongoing, and the specific details of the timetable may still be adjusted. A spokesperson for Syngenta noted that the company will continue to evaluate its capital market strategy based on market conditions and other factors, and plans to return to the capital markets at the right time. The conflict between the US and Iran, as well as the potential closure of the Strait of Hormuz, have impacted the agriculture and fertilizer markets, causing disruptions in the supply of key fertilizer ingredients, including urea, leading to price spikes. With recent tensions between the US and Iran escalating, the supply disruptions may continue. Industry insiders warn that energy prices remain high, and the fertilizer market remains vulnerable to further tensions in the Middle East.